Dopamine is a neurotransmitter with critical roles in the human brain and body, and abnormal dopamine levels underlie brain disorders such as Parkinson’s Disease, Alzheimer’s Disease, and substance addiction. Herein, we present a novel high-throughput biosensor based on graphene multitransistor arrays (gMTAs) functionalized with a selective aptamer for robust ultrasensitive dopamine detection. The miniaturized biosensor integrates multiple electrolyte-gated graphene field-effect transistors (EG-gFETs) in an array configuration, fabricated by high-yield reproducible and scalable methodologies optimized at the wafer level. With these gMTA aptasensors, we reliably detected ultra-low dopamine concentrations in physiological buffers, including undiluted phosphate-buffered saline (PBS), artificial cerebral spinal fluid (aCSF), and high ionic strength complex biological samples. We report a record limit-of-detection (LOD) of 1 aM (10 −18 ) for dopamine in both PBS, and dopamine-depleted brain homogenate samples spiked with dopamine. The gMTAs also display wide sensing ranges across all media, up to 100 μM (10 −8 ), with a 22 mV/decade peak sensitivity in aCSF. Furthermore, we show that the gMTAs can detect minimal changes in dopamine concentrations in small working volume biological CSF samples obtained from a mouse model of Parkinson’s Disease.
Biosensors based on graphene field-effect transistors have become a promising tool for detecting a broad range of analytes. However, they lack the stability and reproducibility required to step into biotechnological and biomedical applications. In this work, we use a controlled in-vacuum physical method for the covalent functionalization of graphene to construct ultrasensitive aptamer-based biosensors (aptasensors) able to detect hepatitis C virus core protein. These devices are highly specific and robust, achieving attomolar detection of the viral protein target in human blood plasma. The improved sensitivity is rationalized by theoretical calculations showing that induced polarization at the graphene interface caused by the proximity of covalently bound probe molecule modulates the charge balance at the graphene/molecule interface. This charge balance causes a net shift of the Dirac cone providing enhanced sensitivity towards the attomolar detection of proteins. Such an unexpected effect paves the way for using this kind of graphene-based platform for real-time diagnostics of different diseases.